scholarly article | Q13442814 |
P50 | author | Xue Li | Q57554800 |
P2093 | author name string | Zhihong Liu | |
Jiong Zhang | |||
Jinsong Chen | |||
Dongrui Cheng | |||
Jiqiu Wen | |||
Mingchao Zhang | |||
Shuming Ji | |||
Kenan Xie | |||
P2860 | cites work | Renal allograft rejection associated with presensitization to HLA-DR antigens | Q72635105 |
Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study | Q81180642 | ||
De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney | Q83199466 | ||
PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy | Q83416838 | ||
C4d deposition and multilayering of peritubular capillary basement membrane in posttransplantation membranous nephropathy indicate its association with antibody-mediated injury | Q83828722 | ||
Human idiopathic membranous nephropathy--a mystery solved? | Q84155266 | ||
Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy | Q84728773 | ||
Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies | Q84758630 | ||
PLA2R Autoantibodies and Recurrent Membranous Nephropathy after Transplantation | Q84984695 | ||
Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy | Q86439847 | ||
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy | Q24652978 | ||
Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study | Q28141871 | ||
Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation | Q30649838 | ||
Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation | Q33827375 | ||
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy | Q34783516 | ||
Anti-phospholipase A2 receptor antibody in membranous nephropathy | Q35012441 | ||
Membranous nephropathy: recent travels and new roads ahead | Q37698191 | ||
De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease? | Q38036393 | ||
Clinical and experimental aspects of renal allograft rejection | Q40324995 | ||
HLA-DR overexpression in tubules of renal allografts during early and late renal allograft injuries | Q42248630 | ||
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
Secondary membranous nephropathy--one center experience | Q46628913 | ||
What is the significance of HLA-DR antigen expression in the extraglomerular mesangium in glomerulonephritis? | Q51318200 | ||
Expression of HLA-DR, -DQ, and -DP antigens on renal tubular cells during rejection episodes | Q68868870 | ||
Diagnosis of renal allograft rejection by analysis of fine-needle aspiration biopsy specimens with immunostains and simple cytology | Q69887398 | ||
Expression of HLA-DR antigens on peripheral blood T lymphocytes and renal graft tubular epithelial cells in association with rejection | Q70155771 | ||
Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon | Q72387795 | ||
Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response | Q72584726 | ||
P433 | issue | 37 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e4809 | |
P577 | publication date | 2016-09-01 | |
P1433 | published in | Medicine | Q15716652 |
P1476 | title | HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy | |
P478 | volume | 95 |
Search more.